vs
Side-by-side financial comparison of Bitcoin Depot Inc. (BTM) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $162.5M, roughly 1.1× Bitcoin Depot Inc.). Bitcoin Depot Inc. runs the higher net margin — 3.4% vs 0.9%, a 2.5% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 20.1%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $2.5M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -4.9%).
Bitcoin Depot Inc. is one of the largest cryptocurrency ATM operators across North America. It provides retail consumers with accessible in-person kiosks to buy and sell Bitcoin and other leading digital assets, alongside online crypto purchase services via bank transfer. Its self-service kiosks are located in high-traffic retail spaces including grocery stores, gas stations and convenience stores.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
BTM vs FOLD — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $162.5M | $185.2M |
| Net Profit | $5.5M | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | 7.3% | 8.6% |
| Net Margin | 3.4% | 0.9% |
| Revenue YoY | 20.1% | 23.7% |
| Net Profit YoY | 690.4% | -88.5% |
| EPS (diluted) | $0.08 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $185.2M | ||
| Q3 25 | $162.5M | $169.1M | ||
| Q2 25 | $172.1M | $154.7M | ||
| Q1 25 | $164.2M | $125.2M | ||
| Q4 24 | — | $149.7M | ||
| Q3 24 | $135.3M | $141.5M | ||
| Q2 24 | $163.1M | $126.7M | ||
| Q1 24 | $138.5M | $110.4M |
| Q4 25 | — | $1.7M | ||
| Q3 25 | $5.5M | $17.3M | ||
| Q2 25 | $6.1M | $-24.4M | ||
| Q1 25 | $4.2M | $-21.7M | ||
| Q4 24 | — | $14.7M | ||
| Q3 24 | $-939.0K | $-6.7M | ||
| Q2 24 | $-2.6M | $-15.7M | ||
| Q1 24 | $-1.5M | $-48.4M |
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 91.1% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | — | 8.6% | ||
| Q3 25 | 7.3% | 20.3% | ||
| Q2 25 | 9.2% | -6.1% | ||
| Q1 25 | 10.8% | -6.3% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | 4.1% | 15.3% | ||
| Q2 24 | 4.7% | 11.8% | ||
| Q1 24 | 0.5% | -25.1% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 3.4% | 10.2% | ||
| Q2 25 | 3.5% | -15.8% | ||
| Q1 25 | 2.6% | -17.3% | ||
| Q4 24 | — | 9.8% | ||
| Q3 24 | -0.7% | -4.8% | ||
| Q2 24 | -1.6% | -12.4% | ||
| Q1 24 | -1.1% | -43.9% |
| Q4 25 | — | $0.00 | ||
| Q3 25 | $0.08 | $0.06 | ||
| Q2 25 | $0.16 | $-0.08 | ||
| Q1 25 | $0.20 | $-0.07 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | $-0.05 | $-0.02 | ||
| Q2 24 | $-0.13 | $-0.05 | ||
| Q1 24 | $-0.25 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $59.3M | $293.5M |
| Total DebtLower is stronger | $67.5M | $392.7M |
| Stockholders' EquityBook value | $21.0M | $274.2M |
| Total Assets | $125.3M | $949.9M |
| Debt / EquityLower = less leverage | 3.21× | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $293.5M | ||
| Q3 25 | $59.3M | $263.8M | ||
| Q2 25 | $48.0M | $231.0M | ||
| Q1 25 | $35.0M | $250.6M | ||
| Q4 24 | — | $249.9M | ||
| Q3 24 | $32.2M | $249.8M | ||
| Q2 24 | $43.9M | $260.1M | ||
| Q1 24 | $42.2M | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | $67.5M | $392.0M | ||
| Q2 25 | $66.5M | $391.3M | ||
| Q1 25 | $56.2M | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | $44.5M | $389.5M | ||
| Q2 24 | $41.2M | $388.9M | ||
| Q1 24 | $37.6M | $388.4M |
| Q4 25 | — | $274.2M | ||
| Q3 25 | $21.0M | $230.4M | ||
| Q2 25 | $4.7M | $204.3M | ||
| Q1 25 | $-4.6M | $193.6M | ||
| Q4 24 | — | $194.0M | ||
| Q3 24 | $-7.9M | $178.8M | ||
| Q2 24 | $4.4M | $132.5M | ||
| Q1 24 | $5.0M | $130.7M |
| Q4 25 | — | $949.9M | ||
| Q3 25 | $125.3M | $868.8M | ||
| Q2 25 | $109.1M | $815.3M | ||
| Q1 25 | $89.7M | $789.8M | ||
| Q4 24 | — | $785.0M | ||
| Q3 24 | $87.4M | $786.6M | ||
| Q2 24 | $97.5M | $749.5M | ||
| Q1 24 | $90.1M | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | 3.21× | 1.70× | ||
| Q2 25 | 14.18× | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | 9.27× | 2.93× | ||
| Q1 24 | 7.54× | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.6M | $16.3M |
| Free Cash FlowOCF − Capex | $2.5M | $16.0M |
| FCF MarginFCF / Revenue | 1.6% | 8.6% |
| Capex IntensityCapex / Revenue | 2.5% | 0.2% |
| Cash ConversionOCF / Net Profit | 1.20× | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $27.1M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $16.3M | ||
| Q3 25 | $6.6M | $35.7M | ||
| Q2 25 | $10.2M | $-26.5M | ||
| Q1 25 | $16.3M | $7.8M | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | $5.8M | $-23.0M | ||
| Q2 24 | $10.1M | $22.7M | ||
| Q1 24 | $1.3M | $-29.7M |
| Q4 25 | — | $16.0M | ||
| Q3 25 | $2.5M | $35.3M | ||
| Q2 25 | $9.8M | $-28.9M | ||
| Q1 25 | $15.9M | $7.5M | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | $-1.0M | $-23.3M | ||
| Q2 24 | $7.6M | $21.6M | ||
| Q1 24 | $789.0K | $-31.5M |
| Q4 25 | — | 8.6% | ||
| Q3 25 | 1.6% | 20.9% | ||
| Q2 25 | 5.7% | -18.7% | ||
| Q1 25 | 9.7% | 6.0% | ||
| Q4 24 | — | -2.8% | ||
| Q3 24 | -0.8% | -16.5% | ||
| Q2 24 | 4.7% | 17.0% | ||
| Q1 24 | 0.6% | -28.5% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | 2.5% | 0.2% | ||
| Q2 25 | 0.2% | 1.6% | ||
| Q1 25 | 0.2% | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 5.0% | 0.3% | ||
| Q2 24 | 1.5% | 0.9% | ||
| Q1 24 | 0.4% | 1.6% |
| Q4 25 | — | 9.62× | ||
| Q3 25 | 1.20× | 2.06× | ||
| Q2 25 | 1.67× | — | ||
| Q1 25 | 3.88× | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BTM
Segment breakdown not available.
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
